Produzione Scientifica
Found 18 results
Filters: Keyword is colitis [Clear All Filters]
PARP1 inactivation increases regulatory T / Th17 cell proportion in intestinal inflammation. Role of HMGB1,
, Immunology Letters, Volume 270, (2024)
PARP1 Activation Induces HMGB1 Secretion Promoting Intestinal Inflammation in Mice and Human Intestinal Organoids,
, International Journal of Molecular Sciences, Volume 24, Number 8, (2023)
Proteomic Analysis Identifies Three Reliable Biomarkers of Intestinal Inflammation in the Stools of Patients With Inflammatory Bowel Disease,
, Journal of Crohn's and Colitis, Jun-08-2024, Volume 17, Issue 1, Number 1, p.92 - 102, (2022)
Dipotassium Glycyrrhizate Improves Intestinal Mucosal Healing by Modulating Extracellular Matrix Remodeling Genes and Restoring Epithelial Barrier Functions,
, Frontiers in Immunology, Feb-04-2021, Volume 10, Number APR, (2019)
Krill oil, vitamin D and Lactobacillus reuteri cooperate to reduce gut inflammation,
, Benef Microbes, 2018 Apr 25, Volume 9, Issue 3, Number 3, p.389-399, (2018)
Transcription Factor ZNF281: A Novel Player in Intestinal Inflammation and Fibrosis,
, Frontiers in immunology, Volume 9, p.2907, (2018)
RIP3 AND pMLKL promote necroptosis-induced inflammation and alter membrane permeability in intestinal epithelial cells,
, Digestive and Liver Disease, Volume 49, Number 11, p.1201-1210, (2017)
Fecal HMGB1 reveals microscopic inflammation in adult and pediatric patients with inflammatory bowel disease in clinical and endoscopic remission,
, Inflammatory Bowel Diseases, Volume 22, Number 12, p.2886-2893, (2016)
NOD2 Is Regulated by MIR-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease,
, Inflammatory Bowel Diseases, Volume 22, Number 2, p.315-326, (2016)
Dipotassium glycyrrhizate via HMGB1 or AMPK signaling suppresses oxidative stress during intestinal inflammation,
, Biochemical Pharmacology, Volume 97, Number 3, p.292-299, (2015)
Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammation,
, American Journal of Gastroenterology, Volume 109, Number 2, p.279-287, (2014)
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease,
, Inflammatory Bowel Diseases, Volume 20, Number 8, p.1448-1457, (2014)
Beyond DNA repair, the immunological role of PARP-1 and its siblings,
, Immunology, Volume 139, Number 4, p.428-437, (2013)
Dipotassium Glycyrrhizate Inhibits HMGB1-Dependent Inflammation and Ameliorates Colitis in Mice,
, PLoS ONE, Volume 8, Number 6, p.e66527, (2013)
Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease,
, Inflammatory Bowel Diseases, Volume 18, Number 5, p.913-924, (2012)
Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease,
, American Journal of Gastroenterology, Volume 106, Number 11, p.2029-2040, (2011)
New insights into the pathogenesis of inflammatory bowel disease: Transcription factors analysis in bioptic tissues from pediatric patients,
, Journal of Pediatric Gastroenterology and Nutrition, Volume 52, Number 3, p.271-279, (2011)
Poly (ADP-Ribose) polymerase-1 (PARP-1) as immune regulator,
, Endocrine, Metabolic and Immune Disorders - Drug Targets, Volume 11, Number 4, p.326-333, (2011)